Cerevel Therapeutics Holdings, Inc.
CERE2024/8/1 下市- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. 已在 2024/8/1 下市；內部人最後一份 Form 4 在 2024/8/5 申報；2024 年第 2 季末有 231 家機構在 13F 申報持有，市值合計 $64.2 億；大師中只有索羅斯基金管理持有。
持有 CERE 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Cerevel Therapeutics Holdings, Inc. 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
目前沒有持有人以 Schedule 13D 或 13G 申報持有 Cerevel Therapeutics Holdings, Inc. 5% 以上的股份。
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Cerevel Therapeutics Holdings, Inc. 的 22 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2024/8/5 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2024/8/5 | Pfizer Inc | 13D/A舊制 | – | – | – | SEC |
| 2024/5/10 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/1/10 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/12/8 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2023/10/18 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2023/10/18 | Pfizer Inc | 13D/A舊制 | – | – | – | SEC |
| 2023/10/17 | Perceptive Advisors LLC | 13D/A舊制 | – | – | – | SEC |
| 2023/4/25 | Perceptive Advisors LLC | 13D/A舊制 | – | – | – | SEC |
| 2023/4/21 | Perceptive Advisors LLC | 13D舊制 | – | 新申報 | – | SEC |
| 2023/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/8/18 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2022/4/7 | Pfizer Inc | 13D/A舊制 | – | – | – | SEC |
| 2022/3/3 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2022/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/9/17 | Pfizer Inc | 13D/A舊制 | – | – | – | SEC |
| 2021/8/10 | FMR LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2021/7/9 | BC Perception Holdings, LP | 13D/A舊制 | – | – | – | SEC |
| 2021/7/9 | Pfizer Inc | 13D/A舊制 | – | – | – | SEC |
| 2021/6/1013:01 ET | Federated Hermes, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2021/4/914:17 ET | Federated Hermes, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2021/2/1215:06 ET | Federated Hermes, Inc. | 13G舊制 | – | 新申報 | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Cerevel Therapeutics Holdings, Inc. 股票的 26 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2024/6/316:58 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $203.7 萬 | 2024/6/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/5/1016:27 ET | Neavelle Anthony Coles董事 | 5.00 萬 | $211.5 萬 | 2024/5/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/4/116:31 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $211.3 萬 | 2024/4/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/3/417:36 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $205.3 萬 | 2024/3/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/2/2916:19 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $206.1 萬 | 2024/2/2910b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/1/216:33 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $212.0 萬 | 2024/1/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/12/2617:03 ET | Ramiro Sanchez高階主管 | 1.00 萬 | $42.5 萬 | 2023/12/2610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/12/2215:56 ET | DiPietro Kenneth高階主管 | 8,000 | $33.2 萬 | 2023/12/22 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| 2023/12/1518:34 ET | Sanchez Ramiro高階主管 | 7,500 | $31.0 萬 | 2023/12/15 | Morgan Stanley Smith Barney LLC Executive Services | SEC |
| 2023/12/716:32 ET | Scott Akamine高階主管 | 1.00 萬 | $41.4 萬 | 2023/12/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/12/716:31 ET | Ramiro Sanchez高階主管 | 1.00 萬 | $41.4 萬 | 2023/12/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/12/518:42 ET | Scott Akamine高階主管 | 7,500 | $26.3 萬 | 2023/12/510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/11/716:13 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $124.8 萬 | 2023/11/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/11/316:25 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $124.4 萬 | 2023/11/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/11/216:05 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $126.8 萬 | 2023/11/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/11/116:39 ET | Deval Patrick董事 | 3.01 萬 | $75.3 萬 | 2023/11/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/9/716:17 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $121.3 萬 | 2023/9/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/7/1116:27 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $152.9 萬 | 2023/7/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/6/1516:36 ET | Novalis LifeSciences Investments I, L.P.Stockholder (1) see Remarks | 20.0 萬 | $688.6 萬 | 2023/6/15 | Cowan and Company, LLC | SEC |
| 2023/6/520:52 ET | Bodenrader Mark高階主管 | 1,895 | $6.24 萬 | 2023/6/2 | ETRADE FINANCIAL CORPORATION | SEC |
| 2023/6/116:19 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $163.0 萬 | 2023/6/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/5/819:03 ET修正 | Ceesay Abraham高階主管 | 3.52 萬 | $112.7 萬 | 2023/5/8 | ETRADE FINANCIAL CORPORATION | SEC |
| 2023/5/515:15 ET | Ceesay Abraham高階主管 | 3.52 萬 | $110.6 萬 | 2023/5/5 | ETRADE FINANCIAL CORPORATION | SEC |
| 2023/5/416:31 ET | Neavelle Anthony Coles董事 · 高階主管 | 5.00 萬 | $159.6 萬 | 2023/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/5/414:50 ET | Ceesay Abraham高階主管 | 3.52 萬 | $112.4 萬 | 2023/5/4 | ETRADE FINANCIAL CORPORATION | SEC |
只列最新的 25 份。看 CERE 近 12 個月的全部通知